Business Description
IM Cannabis Corp. specializes in the cultivation, production, and provision of medicinal cannabis goods throughout international markets such as Israel, Germany, and Canada. The company offers a range of cannabis products, including flowers and specifically formulated cannabis extracts, marketed under its IMC brand. Furthermore, it supplies dried flower, pre-rolled products, and compressed hashish via its WAGNERS and Highland Grow labels. IM Cannabis Corp. serves a broad customer base, addressing the needs of both medical patients and adult recreational consumers. Its corporate headquarters are located in Tel Aviv-Yafo, Israel.
Business History
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): -2.67
Total Equity: -$858,000
Shares: 4,239,326
Total Debt: $15.89M
Cash: $2.73M
EBITDA: -$6.95M
Total Debt: $15.89M
Cash: $2.73M
Revenue: $54.73M
Shares: 4,239,326
Revenue: $54.73M
Revenue: $54.73M
Revenue: $54.73M
Total Equity: -$858,000
Tax Rate: -0.8%
Equity: -$858,000
Total Debt: $15.89M
Cash: $2.73M
Current Liabilities: $34.01M
Long-Term Debt: $936,000
Total Debt: $15.89M
Total Equity: -$858,000
Shares: 4,239,326
Shares: 4,239,326
CapEx: -$13,000
Shares: 4,239,326
Stock Price: $0.14
Net Income: -$11.32M
Industry Benchmarks
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement (Annual)
Last updated: Jun 25, 2026 1:44am (2d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $34.1M | $54.3M | $48.8M | $54.0M | $54.7M |
| Cost of Revenue | $27.7M | $45.2M | $39.0M | $45.6M | $45.0M |
| Gross Profit | $6.3M | $9.2M | $9.8M | $8.5M | $9.7M |
| Operating Expenses | $29.4M | $40.0M | $22.6M | $18.7M | $21.3M |
| Operating Income | -$23.0M | -$30.8M | -$12.8M | -$10.2M | -$11.6M |
| Net Income | -$17.8M | -$188.9M | -$9.5M | -$10.6M | -$11.3M |
| EBITDA | $6.2M | -$16.8M | -$2.8M | -$6.1M | -$6.9M |
| EPS | $-5.71 | $-76.80 | $-4.45 | $-4.51 | $-2.67 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 25, 2026 1:44am (2d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $13.9M | $2.4M | $1.8M | $863,000 | $2.7M |
| Total Current Assets | $81.2M | $32.7M | $24.3M | $23.4M | $22.7M |
| Total Assets | $287.4M | $60.7M | $48.8M | $39.2M | $31.7M |
| Current Liabilities | $51.2M | $33.8M | $32.8M | $34.9M | $34.0M |
| Long-Term Debt | $392,000 | $399,000 | $394,000 | $466,000 | $936,000 |
| Total Liabilities | $82.4M | $36.9M | $35.1M | $36.0M | $35.4M |
| Total Equity | $201.2M | $22.7M | $14.5M | $5.2M | $-858,000 |
| Retained Earnings | -$50.7M | -$238.9M | -$249.1M | -$258.9M | -$270.2M |
Cash Flow (Annual)
Last updated: Jun 25, 2026 1:44am (2d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$34.4M | -$12.6M | -$8.1M | -$1.1M | $4.7M |
| Capital Expenditure | -$4.6M | -$1.6M | $-581,000 | $-156,000 | $-13,000 |
| Free Cash Flow | -$39.0M | -$14.2M | -$8.7M | -$1.2M | $4.7M |
| Acquisitions (net) | -$12.5M | $-406,000 | $0 | $-346,000 | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $5.0M | -$11.5M | $-636,000 | $-950,000 | $1.9M |
Analyst Estimates (Annual)
Last updated: Jun 26, 2026 6:50pm (15h ago)| Metric | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Revenue |
$38.4M $36.6M – $40.1M
|
$38.4M $38.4M – $38.4M
|
$54.3M $54.3M – $54.3M
|
$62.8M $62.8M – $62.8M
|
| EBITDA |
-$3.2M -$3.4M – -$3.1M
|
-$3.3M -$3.3M – -$3.3M
|
-$4.6M -$4.6M – -$4.6M
|
-$5.3M -$5.3M – -$5.3M
|
| Net Income |
-$11.4M -$11.4M – -$11.4M
|
-$16.1M -$16.1M – -$16.1M
|
-$1.3M -$1.3M – -$1.3M
|
-$1.4M -$1.4M – -$1.4M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 25, 2026 1:44am (2d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +59.6% | -10.2% | +10.7% | +1.3% |
| Gross Profit Growth | +44.7% | +7.5% | -14.2% | +14.6% |
| Operating Income Growth | -33.7% | +58.5% | +20.0% | -13.2% |
| Net Income Growth | -963.4% | +95.0% | -11.4% | -6.9% |
| EBITDA Growth | -368.6% | +83.4% | -120.2% | -13.1% |
Narrative Economics
market-narrative step).